These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11989190)

  • 1. Cholesterol emboli syndrome occurring after administration of tissue plasminogen activator.
    Baldwin SH; Musa J
    J Miss State Med Assoc; 2002 Apr; 43(4):108. PubMed ID: 11989190
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholesterol embolization syndrome following thrombolytic therapy with streptokinase and tissue plasminogen activator.
    Ben-Chitrit S; Korzets Z; Hershkovitz R; Bernheim J; Schneider M; Bernheim J
    Nephrol Dial Transplant; 1994; 9(4):428-30. PubMed ID: 8084460
    [No Abstract]   [Full Text] [Related]  

  • 3. Purple toes syndrome following stroke thrombolysis and warfarin therapy.
    Mooney T; Joseph P
    Intern Med J; 2014 Jan; 44(1):107-8. PubMed ID: 24450530
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cholesterol crystal embolisms due to systemic thrombolysis of an acute myocardial infarct].
    Diethelm A; Vorburger C; Anabitarte M; Haag E
    Schweiz Med Wochenschr; 1994 Aug; 124(33):1437-41. PubMed ID: 7939511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol embolization after systemic streptokinase.
    Wright DA; Forni LG; Carr P; Hilton PJ; Tungekar MF
    Br J Hosp Med; 1997 Jan 15-Feb 5; 57(1-2):51-2. PubMed ID: 9022828
    [No Abstract]   [Full Text] [Related]  

  • 6. Anaphylactoid reaction to recombinant tissue plasminogen activator.
    Krmpotic KR; Fernandes CM
    Eur J Emerg Med; 2007 Feb; 14(1):60-1. PubMed ID: 17198333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraventricular tissue plasminogen activator toxicity.
    Gaberel T; Emery E
    Neurosurgery; 2011 Jan; 68(1):E288-9; author reply E289. PubMed ID: 21150745
    [No Abstract]   [Full Text] [Related]  

  • 8. [Upper airway obstruction by angioedema following thrombolytic therapy with recombinant tissue plasminogen activator].
    García-Jiménez A; Iriarte Sotés P; Fernández González CJ; Garrote Freire A; González Tutor J
    An Med Interna; 2003 Mar; 20(3):163-4. PubMed ID: 12756909
    [No Abstract]   [Full Text] [Related]  

  • 9. Thrombolytic therapy in patients with submassive pulmonary embolism.
    Dalen JE
    N Engl J Med; 2003 Jan; 348(4):357-9; author reply 357-9. PubMed ID: 12542064
    [No Abstract]   [Full Text] [Related]  

  • 10. [Orolingual angioedema secondary to alteplase treatment in cases of stroke].
    Giménez-Muñoz A; Capablo-Liesa JL; Torné-Hernández L; Sagarra-Mur D; Sebastián-Torres B; Alarcia-Alejos R
    Rev Neurol; 2008 Mar 16-31; 46(6):382. PubMed ID: 18368687
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholesterol embolization after treatment with tissue plasminogen activator.
    Shapiro LS
    N Engl J Med; 1989 Nov; 321(18):1270. PubMed ID: 2507919
    [No Abstract]   [Full Text] [Related]  

  • 12. Predictors of major hemorrhage following fibrinolysis for acute pulmonary embolism.
    Fiumara K; Kucher N; Fanikos J; Goldhaber SZ
    Am J Cardiol; 2006 Jan; 97(1):127-9. PubMed ID: 16377297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolysis induces cerebral hemorrhage in a mouse model of cerebral amyloid angiopathy.
    Winkler DT; Biedermann L; Tolnay M; Allegrini PR; Staufenbiel M; Wiessner C; Jucker M
    Ann Neurol; 2002 Jun; 51(6):790-3. PubMed ID: 12112090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolysis for stroke in the over 80s.
    Ford GA
    Age Ageing; 2004 Mar; 33(2):95-7. PubMed ID: 14960420
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fatal massive hemoptysis during thrombolysis of acute ischemic stroke].
    de la Torre-Laviana FJ; Redondo L; Antunez-Infante A; Alvarez-Marquez E
    Rev Neurol; 2006 Oct 16-31; 43(8):510-1. PubMed ID: 17033985
    [No Abstract]   [Full Text] [Related]  

  • 16. Tissue plasminogen activator: beyond thrombolysis.
    Benarroch EE
    Neurology; 2007 Aug; 69(8):799-802. PubMed ID: 17709713
    [No Abstract]   [Full Text] [Related]  

  • 17. Review of tissue plasminogen activator, ischemic stroke, and potential legal issues.
    Liang BA; Lew R; Zivin JA
    Arch Neurol; 2008 Nov; 65(11):1429-33. PubMed ID: 19001160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral retinal ischemia after intravenous tissue plasminogen activator for central retinal artery occlusion.
    Joseph A; Rahimy E; Sarraf D
    Can J Ophthalmol; 2014 Oct; 49(5):e127-9. PubMed ID: 25284117
    [No Abstract]   [Full Text] [Related]  

  • 19. Reperfusion seizures: a manifestation of cerebral reperfusion injury after administration of recombinant tissue plasminogen activator for acute ischemic stroke.
    Hafeez F; Razzaq MA; Levine RL; Ramirez MA
    J Stroke Cerebrovasc Dis; 2007; 16(6):273-7. PubMed ID: 18035246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hazards of thrombolytic therapy for stroke: the real-world experience.
    Hurley JC
    Intern Med J; 2007 May; 37(5):348-9; author reply 349-50. PubMed ID: 17504292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.